Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

41 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Interim Effectiveness Estimates of 2024 Southern Hemisphere Influenza Vaccines in Preventing Influenza-Associated Hospitalization - REVELAC-i Network, Five South American Countries, March-July 2024.
Zeno EE, Nogareda F, Regan A, Couto P, Rondy M, Jara J, Voto C, Rojas Mena MP, Katz N, Del Valle Juarez M, Benedetti E, de Paula Júnior FJ, Ferreira da Almeida WA, Hott CE, Ferrari PR, Mallegas NV, Vigueras MA, Domínguez C, von Horoch M, Vazquez C, Silvera E, Chiparelli H, Goni N, Castro L, Marcenac P, Kondor RJ, Leite J, Velandia M, Azziz-Baumgartner E, Fowlkes AL, Salas D; REVELAC-i Network. Zeno EE, et al. Among authors: fowlkes al. MMWR Morb Mortal Wkly Rep. 2024 Oct 3;73(39):861-868. doi: 10.15585/mmwr.mm7339a1. MMWR Morb Mortal Wkly Rep. 2024. PMID: 39361525 Free PMC article.
Interim Effectiveness Estimates of 2023 Southern Hemisphere Influenza Vaccines in Preventing Influenza-Associated Hospitalizations - REVELAC-i Network, March-July 2023.
Fowlkes AL, Nogareda F, Regan A, Loayza S, Mancio JM, Duca LM, Couto P, Leite J, Rodriguez A, Salas D, Azziz-Baumgartner E; REVELAC–i Network. Fowlkes AL, et al. MMWR Morb Mortal Wkly Rep. 2023 Sep 15;72(37):1010-1015. doi: 10.15585/mmwr.mm7237e1. MMWR Morb Mortal Wkly Rep. 2023. PMID: 37708084 Free PMC article. No abstract available.
Effectiveness of COVID-19 vaccines against hospitalisation in Latin America during three pandemic waves, 2021-2022: a test-negative case-control design.
Nogareda F, Regan AK, Couto P, Fowlkes AL, Gharpure R, Loayza S, Leite JA, Rodríguez A, Vicari A, Azziz-Baumgartner E, Salas D; REVELAC-i Working Group. Nogareda F, et al. Among authors: fowlkes al. Lancet Reg Health Am. 2023 Nov 10;27:100626. doi: 10.1016/j.lana.2023.100626. eCollection 2023 Nov. Lancet Reg Health Am. 2023. PMID: 38035125 Free PMC article.
Influenza incidence, lineages, and vaccine effectiveness estimates in Lima, Peru, 2023.
Acevedo-Rodriguez JG, Zamudio C, Kojima N, Krapp F, Tsukayama P, Sal Y Rosas Celi VG, Baldeon D, Neciosup-Vera CS, Medina C, Gonzalez-Lagos E, Castro L, Fowlkes A, Azziz-Baumgartner E, Gotuzzo E; PISAAC working group. Acevedo-Rodriguez JG, et al. Lancet Microbe. 2024 Apr;5(4):e308-e309. doi: 10.1016/S2666-5247(23)00392-0. Epub 2024 Jan 11. Lancet Microbe. 2024. PMID: 38219756 Free PMC article. No abstract available.
Effectiveness of 2023 southern hemisphere influenza vaccines against severe influenza-associated illness: pooled estimates from eight countries using the test-negative design.
Gharpure R, Regan AK, Nogareda F, Cheng AC, Blyth CC, George SS, Huang QS, Wood T, Anglemyer A, Prasert K, Praphasiri P, Davis WW, Pittayawonganon C, Ercole R, Iturra A, de Almeida WAF, de Paula Júnior FJ, Vigueras MA, Barraza MFO, Domínguez C, Penayo E, Goñi N, Tritten D, Couto P, Salas D, Fowlkes AL, Duca LM, Azziz-Baumgartner E, Sullivan SG. Gharpure R, et al. Among authors: fowlkes al. Lancet Glob Health. 2025 Feb;13(2):e203-e211. doi: 10.1016/S2214-109X(24)00473-X. Lancet Glob Health. 2025. PMID: 39890222 Free PMC article.
Seasonal Influenza Vaccination Programs in the Americas: A Platform for Sustainable Life-Course Immunization and Its Role for Pandemic Preparedness and Response.
Nogareda F, Ghiselli M, Velandia-González M, de Mucio B, Jara J, Couto P, Rodriguez A, Rondy M, Vicari A, Ozturk MH, Goldin S, Vilajeliu A, Leidman E, Patel J, Carlton J, Fowlkes AL, Azziz-Baumgartner E, Salas Peraza D, Ropero AM. Nogareda F, et al. Among authors: fowlkes al. Vaccines (Basel). 2024 Dec 16;12(12):1415. doi: 10.3390/vaccines12121415. Vaccines (Basel). 2024. PMID: 39772075 Free PMC article. Review.
Randomised immunogenicity trial comparing 2019-2020 recombinant and egg-based influenza vaccines among frequently vaccinated healthcare personnel in Israel.
Fowlkes AL, Peretz A, Greenberg D, Hirsch A, Martin ET, Levine MZ, Edwards L, Radke S, Lauring AS, Ferdinands JM, Zhang C, Yoo YM, Dreiher J, Newes-Adeyi G, Azziz-Baumgartner E, Fry AM, Monto AS, Balicer R, Thompson MG, Katz MA. Fowlkes AL, et al. Int J Infect Dis. 2024 Dec;149:107260. doi: 10.1016/j.ijid.2024.107260. Epub 2024 Oct 10. Int J Infect Dis. 2024. PMID: 39395753 Free PMC article. Clinical Trial.
Evaluating Immunologic and Illness Outcomes of SARS-CoV-2 Infection in Vaccinated and Unvaccinated Children Aged ≥ 5 Years, in a Multisite Longitudinal Cohort.
Porter C, Lyski ZL, Uhrlaub JL, Ellingson KD, Jeddy Z, Gwynn L, Rivers P, Sprissler R, Hegmann KT, Coughlin MM, Fowlkes AL, Hollister J, LeClair L, Mak J, Beitel SC, Fuller S, Zheng PQ, Vaughan M, Rai RP, Grant L, Newes-Adeyi G, Yoo YM, Olsho L, Burgess JL, Caban-Martinez AJ, Yoon SK, Britton A, Gaglani M, Phillips AL, Thiese MS, Hagen MB, Jones JM, Lutrick K. Porter C, et al. Among authors: fowlkes al. Diseases. 2024 Aug 1;12(8):171. doi: 10.3390/diseases12080171. Diseases. 2024. PMID: 39195170 Free PMC article.
Longitudinal parental perception of COVID-19 vaccines for children in a multi-site, cohort study.
Rivers P, Porter C, LeClair LB, Jeddy Z, Fowlkes AL, Lamberte JM, Herder K, Smith M, Rai R, Grant L, Hegmann KT, Jovel K, Vaughan M, Mathenge C, Phillips AL, Khan S, Britton A, Pilishvili T, Burgess JL, Newes-Adeyi G, Gaglani M, Caban-Martinez A, Yoon S, Lutrick K; PROTECT network. Rivers P, et al. Among authors: fowlkes al. Vaccine. 2024 Mar 7;42(7):1512-1520. doi: 10.1016/j.vaccine.2024.01.016. Epub 2024 Feb 2. Vaccine. 2024. PMID: 38307743 Free PMC article.
Serum per- and polyfluoroalkyl substance concentrations and longitudinal change in post-infection and post-vaccination SARS-CoV-2 antibodies.
Hollister J, Caban-Martinez AJ, Ellingson KD, Beitel S, Fowlkes AL, Lutrick K, Tyner HL, Naleway AL, Yoon SK, Gaglani M, Hunt D, Meece J, Mayo Lamberte J, Schaefer Solle N, Rose S, Dunnigan K, Khan SM, Kuntz JL, Fisher JM, Coleman A, Britton A, Thiese MS, Hegmann KT, Pavuk M, Ramadan FA, Fuller S, Nematollahi A, Sprissler R, Burgess JL. Hollister J, et al. Among authors: fowlkes al. Environ Res. 2023 Dec 15;239(Pt 1):117297. doi: 10.1016/j.envres.2023.117297. Epub 2023 Oct 8. Environ Res. 2023. PMID: 37816422 Free PMC article.
41 results